Key Takeaways
- Robert Califf’s final Capitol Hill appearance focused on food and nutrition, an issue that dominated much of his most recent tenure leading the FDA.
- The discussion about food industry greed driving chronic illness could signal areas for agreement between Democrats and HHS Secretary nominee Robert F. Kennedy Jr.
- The conundrum that the FDA allows people to gain weight through poor diet and also approves expensive weight loss treatments likely will remain a theme during the Trump Administration.
A 5 December Senate Health, Education, Labor and Pensions Committee hearing was an appropriate send off for outgoing US Food and Drug Administration Commissioner Robert Califf.
The hearing focused on the FDA’s food and nutrition operations, including the link between packaged foods and public health. The hearing title, courtesy of HELP Committee Chair Bernie Sanders,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?